China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2017
(WorldNews China)

China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2017 3Q17 Added 19,712 New Subscribers 3Q17 Revenue Up 18.6% YOY to RMB200.9 Million ($28.9 Million) 3Q17 Operating Income Reached RMB101.7 Million ($14.6 Million) Conference Call to be Held on February 27, 2017 at 8:00 a.m. ET HONG KONG, China, February 24, 2017 -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China`s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for the third quarter and first nine months of...